EUVIMEDEUVIMED entdecken
Crossref

Towards better outcomes: segmentectomy for ground-glass opacity-dominant non-small cell lung cancer 3 cm or less—insights from JCOG1211

Terumoto Koike, Toshiki Hasebe, Masaya Nakamura, Yuki Shimizu, Tatsuya Goto, Masanori Tsuchida

AME Clinical Trials Review · 2023

DOI: 10.21037/actr-23-10 ↗

Kurz gefasst

Fachartikel in der Zeitschrift AME Clinical Trials Review, 2023. Verfasst von Terumoto Koike und 5 weiteren Autor:innen.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Zitieren

APA

Koike, T., Hasebe, T., Nakamura, M., Shimizu, Y., Goto, T., & Tsuchida, M. (2023). Towards better outcomes: segmentectomy for ground-glass opacity-dominant non-small cell lung cancer 3 cm or less—insights from JCOG1211. AME Clinical Trials Review. https://doi.org/10.21037/actr-23-10

Vancouver

Koike T, Hasebe T, Nakamura M, Shimizu Y, Goto T, Tsuchida M. Towards better outcomes: segmentectomy for ground-glass opacity-dominant non-small cell lung cancer 3 cm or less—insights from JCOG1211. AME Clinical Trials Review. 2023. doi:10.21037/actr-23-10

BibTeX
@article{Koike2023,
  author = {Koike, Terumoto and Hasebe, Toshiki and Nakamura, Masaya and Shimizu, Yuki and Goto, Tatsuya and Tsuchida, Masanori},
  title = {Towards better outcomes: segmentectomy for ground-glass opacity-dominant non-small cell lung cancer 3 cm or less—insights from JCOG1211},
  journal = {AME Clinical Trials Review},
  year = {2023},
  doi = {10.21037/actr-23-10}
}
Kostenlos starten →